Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Cancer biomarker determination by resonance energy transfer using functional fluorescent nanoprobes.

Das P, Sedighi A, Krull UJ.

Anal Chim Acta. 2018 Dec 24;1041:1-24. doi: 10.1016/j.aca.2018.07.060. Epub 2018 Jul 26. Review.

PMID:
30340680
2.

Back and forth between cancer treatment and cancer control programs: Insights from the Cuban experience.

Lage A, Romero T.

Semin Oncol. 2018 Jan;45(1-2):12-17. doi: 10.1053/j.seminoncol.2018.04.004. Epub 2018 Apr 30. Review.

3.

Pediatric Solid Tumors in Children and Adolescents: An Overview.

Allen-Rhoades W, Whittle SB, Rainusso N.

Pediatr Rev. 2018 Sep;39(9):444-453. doi: 10.1542/pir.2017-0268. Review. No abstract available.

PMID:
30171055
4.

Early diagnosis of disease using microbead array technology: A review.

Parsa SF, Vafajoo A, Rostami A, Salarian R, Rabiee M, Rabiee N, Rabiee G, Tahriri M, Yadegari A, Vashaee D, Tayebi L, Hamblin MR.

Anal Chim Acta. 2018 Nov 22;1032:1-17. doi: 10.1016/j.aca.2018.05.011. Epub 2018 May 4. Review.

PMID:
30143206
5.

Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancers.

Huang L, Jiang X, Wang Z, Zhong X, Tai S, Cui Y.

Pathol Res Pract. 2018 Sep;214(9):1247-1252. doi: 10.1016/j.prp.2018.07.033. Epub 2018 Aug 2. Review.

PMID:
30107989
6.

CXCR4-directed theranostics in oncology and inflammation.

Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C.

Ann Nucl Med. 2018 Oct;32(8):503-511. doi: 10.1007/s12149-018-1290-8. Epub 2018 Aug 13. Review.

7.

Circular RNA, a novel marker for cancer determination (Review).

Su Y, Zhong G, Jiang N, Huang M, Lin T.

Int J Mol Med. 2018 Oct;42(4):1786-1798. doi: 10.3892/ijmm.2018.3795. Epub 2018 Jul 30. Review.

PMID:
30066837
8.

Pediatric Oncologic Emergencies.

Stephanos K, Picard L.

Emerg Med Clin North Am. 2018 Aug;36(3):527-535. doi: 10.1016/j.emc.2018.04.007. Epub 2018 Jun 11. Review.

PMID:
30037439
9.

Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment.

Fu LH, Qi C, Lin J, Huang P.

Chem Soc Rev. 2018 Aug 28;47(17):6454-6472. doi: 10.1039/c7cs00891k. Review.

PMID:
30024579
10.

Krüppel-like factor 4 expression in solid tumor prognosis: A meta-analysis.

Yu M, Hao B, Zhan Y, Luo G.

Clin Chim Acta. 2018 Oct;485:50-59. doi: 10.1016/j.cca.2018.06.030. Epub 2018 Jun 22. Review.

PMID:
29940144
11.

The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.

Zuo XL, Cai J, Chen ZQ, Zhang Y, Liang LH, Wang JF, Wang JG, Wu J, Mao JD.

Clin Chim Acta. 2018 Oct;485:14-20. doi: 10.1016/j.cca.2018.06.018. Epub 2018 Jun 12. Review.

PMID:
29906419
12.

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day.

Uguen A, Troncone G.

J Clin Pathol. 2018 Sep;71(9):757-762. doi: 10.1136/jclinpath-2018-205189. Epub 2018 Jun 14. Review. No abstract available.

PMID:
29903742
13.

"No pain, No gain" still true with immunotherapy: When the finger shows the moon, look at the moon!

Milano G, Innocenti F, Lacarelle B, Ciccolini J.

Crit Rev Oncol Hematol. 2018 Jul;127:1-5. doi: 10.1016/j.critrevonc.2018.04.003. Epub 2018 Apr 17. Review.

PMID:
29891106
14.

LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.

Chen C, Feng Y, Wang X.

Clin Chim Acta. 2018 Sep;484:265-271. doi: 10.1016/j.cca.2018.06.007. Epub 2018 Jun 6. Review.

PMID:
29885321
15.

DNA Nanotechnology for Cancer Diagnosis and Therapy.

Chen T, Ren L, Liu X, Zhou M, Li L, Xu J, Zhu X.

Int J Mol Sci. 2018 Jun 5;19(6). pii: E1671. doi: 10.3390/ijms19061671. Review.

16.

Metabolic syndrome and cancer: "The common soil hypothesis".

Bellastella G, Scappaticcio L, Esposito K, Giugliano D, Maiorino MI.

Diabetes Res Clin Pract. 2018 Sep;143:389-397. doi: 10.1016/j.diabres.2018.05.024. Epub 2018 May 26. Review.

PMID:
29807099
17.

Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.

Shumilov E, Flach J, Pabst T, Fiedler M, Angelillo-Scherrer A, Trümper L, Joncourt R, Kohlmann A, Bacher U.

Crit Rev Oncol Hematol. 2018 Jun;126:64-79. doi: 10.1016/j.critrevonc.2018.03.020. Epub 2018 Mar 29. Review.

PMID:
29759569
18.

Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms.

Nieder C, Mehta MP, Geinitz H, Grosu AL.

Crit Rev Oncol Hematol. 2018 Jun;126:13-18. doi: 10.1016/j.critrevonc.2018.03.018. Epub 2018 Mar 29. Review.

PMID:
29759555
19.

Nano-biosensors in cellular and molecular biology.

Moradi S, Khaledian S, Abdoli M, Shahlaei M, Kahrizi D.

Cell Mol Biol (Noisy-le-grand). 2018 Apr 30;64(5):85-90. Review.

PMID:
29729711
20.

Prognostic value of PEG10 in Asian solid tumors: A meta-analysis.

Ge H, Yan Y, Wu D, Huang Y, Tian F.

Clin Chim Acta. 2018 Aug;483:197-203. doi: 10.1016/j.cca.2018.04.041. Epub 2018 May 1. Review.

PMID:
29727698

Supplemental Content

Loading ...
Support Center